The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, 222 East 41st Street, 24th Floor, New York, NY, 10017, USA.
University of California San Francisco, San Francisco, CA, USA.
Am J Clin Dermatol. 2022 Mar;23(2):137-151. doi: 10.1007/s40257-021-00662-z. Epub 2021 Dec 13.
People of African, Asian, Hispanic or Latino, Pacific Islander, and Native Indian descent are considered people of color by the Skin of Color Society (SOCS).
In this study, we assess incidence, risk factors, clinical characteristics, histopathology, treatment, and survival for skin malignancies in people of color as defined by the SOCS, by systematically reviewing the literature.
An electronic literature search of the PubMed, EMBASE, and MEDLINE databases was performed. Articles published from 1 January 1990 through 12 December 2020 were included in the search.
We identified 2666 publications potentially meeting the study criteria. Titles and abstracts of these studies were reviewed and 2353 were excluded. The full text of 313 articles were evaluated and 251 were included in this review.
Differences in incidence, patterns, treatment, and survival exist among people of color for cutaneous malignancies. Further research and initiatives are needed to account for and mitigate these differences.
皮肤颜色社会(SOCS)将非洲裔、亚洲裔、西班牙裔或拉丁裔、太平洋岛民和本土印第安人定义为有色人种。
在这项研究中,我们通过系统地回顾文献,评估 SOCS 定义的有色人种的皮肤恶性肿瘤的发病率、危险因素、临床特征、组织病理学、治疗和生存情况。
对 PubMed、EMBASE 和 MEDLINE 数据库进行电子文献检索。纳入的检索时间为 1990 年 1 月 1 日至 2020 年 12 月 12 日期间发表的文章。
我们共检索到 2666 篇可能符合研究标准的文献。对这些研究的标题和摘要进行了审查,排除了 2353 篇。评估了 313 篇文章的全文,其中 251 篇被纳入本综述。
皮肤恶性肿瘤在有色人种中的发病率、模式、治疗和生存情况存在差异。需要进一步的研究和倡议来考虑和减轻这些差异。